Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
18°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Health & Science
Recent news which mentions Health & Science
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Gilead Sciences alleges dangerous drug-counterfeiting operation at two NYC pharmacies in lawsuit
August 16, 2024
Tags
Gilead Sciences Inc
Crime
Business
From
CNBC.com News
Mpox vaccine maker Bavarian Nordic seeks ‘critical’ EU approval for teens after WHO declares health emergency
August 16, 2024
Tags
Health care industry
Pharmaceuticals
Health & Science
From
CNBC.com News
What's next for the Biden administration's Medicare drug price negotiations
August 15, 2024
Tags
Business News
Biotechnology
Biotech and Pharmaceuticals
From
CNBC.com News
Health stocks jump as WHO declares mpox global health emergency
August 15, 2024
Tags
Health & Science
Pharmaceuticals
Health care industry
From
CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
August 15, 2024
Tags
Business News
Breaking News: Business
Biotechnology
From
CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
August 14, 2024
Tags
Health care industry
Healthy Returns
Novo Nordisk A/S
From
CNBC.com News
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
August 13, 2024
Tags
Biotech and Pharmaceuticals
Biotechnology
Business News
From
CNBC.com News
Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar
August 08, 2024
Tags
Pharmaceuticals
Health & Science
Eli Lilly and Co
From
CNBC.com News
CVS slashes profit outlook on higher medical costs, says top Aetna executive will leave
August 07, 2024
Tags
Business
Breaking News: Earnings
Health care industry
From
CNBC.com News
Wegovy maker Novo Nordisk posts earnings miss, cuts operating profit outlook
August 07, 2024
Tags
Markets
Breaking News: Europe
Medicine
From
CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
August 06, 2024
Tags
Biotech and Pharmaceuticals
Novartis AG
Healthy Returns
From
CNBC.com News
Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
August 02, 2024
Tags
Health & Science
Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
Your health records are coming to new apps. Here's why
August 01, 2024
Tags
Health & Science
Health care industry
Technology
From
CNBC.com News
Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
August 01, 2024
Tags
Companies
Business
Health care industry
From
CNBC.com News
Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
August 01, 2024
Tags
Health & Science
Pharmaceuticals
US: News
From
CNBC.com News
Moderna beats estimates but slashes guidance on low EU sales, competitive U.S. vaccine market
August 01, 2024
Tags
Health & Science
Pharmaceuticals
Merck & Co Inc
From
CNBC.com News
23andMe CEO files proposal to take company private as stock craters
July 31, 2024
Tags
Breaking News: Technology
Mobile
Enterprise
From
CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
July 31, 2024
Tags
Zealand Pharma A/S
Augmedix Inc
Viking Therapeutics Inc
From
CNBC.com News
Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says
July 30, 2024
Tags
Biotech and Pharmaceuticals
Biotechnology
Breaking News: Business
From
CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
July 30, 2024
Tags
Health care industry
Biogen Inc
Business
From
CNBC.com News
Neuralink rival Synchron lets patients control Apple Vision Pro with their thoughts
July 30, 2024
Tags
Apple Inc
Mobile
Health & Science
From
CNBC.com News
Pfizer beats earnings estimates, hikes full-year outlook as drugmaker cuts costs
July 30, 2024
Tags
Pharmaceuticals
Health & Science
Pfizer Inc
From
CNBC.com News
Merck beats earnings expectations, raises sales outlook on strong demand for top drugs like Keytruda
July 30, 2024
Tags
Business
Health care industry
Breaking News: Earnings
From
CNBC.com News
Dexcom shares plunge more than 40%, head for worst day on record
July 26, 2024
Tags
Health & Science
US: News
Health Care Supplies
From
CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
July 26, 2024
Tags
Companies
Health care industry
Business
From
CNBC.com News
Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs
July 26, 2024
Tags
US: News
Earnings
Pharmaceuticals
From
CNBC.com News
Dexcom shares plummet more than 30% after company lowers fiscal year guidance
July 25, 2024
Tags
Earnings
Breaking News: Technology
Enterprise
From
CNBC.com News
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
July 25, 2024
Tags
Health care industry
Business
Breaking news
From
CNBC.com News
GE HealthCare taps Amazon Web Services to build generative AI for medical use
July 25, 2024
Tags
US: News
Mobile
Health & Science
From
CNBC.com News
India is on alert after a fresh outbreak of the deadly Nipah virus. Here’s what you need to know
July 25, 2024
Tags
World News
Europe News
Health & Science
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.